CCP
GSK icon

Clifford Capital Partners’s GSK GSK Stock Holding History

Clifford Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-409,669
Closed -$16.7M – 51
2024
Q3 		$16.7M Buy
409,669
+51,378
+14% +$2.1M 3.34% 12
2024
Q2 		$13.8M Buy
358,291
+63,033
+21% +$2.65M 3% 20
2024
Q1 		$12.7M Buy
295,258
+8,046
+3% +$332K 3.21% 15
2023
Q4 		$10.6M Buy
287,212
+6,971
+2% +$250K 2.75% 21
2023
Q3 		$10.2M Buy
280,241
+13,934
+5% +$495K 2.96% 20
2023
Q2 		$9.49M Sell
266,307
-448
-0.2% -$16.1K 2.75% 19
2023
Q1 		$9.49M Buy
266,755
+4,788
+2% +$168K 2.92% 20
2022
Q4 		$9.21M Buy
261,967
+59,641
+29% +$1.99M 2.8% 22
2022
Q3 		$5.95M Buy
202,326
+390
+0.2% +$14.8K 2.55% 20
2022
Q2 		$11.2M Buy
201,936
+73,482
+57% +$4.06M 4.47% 3
2022
Q1 		$6.99M Buy
128,454
+37,361
+41% +$2.03M 3.77% 8
2021
Q4 		$5.02M Buy
91,093
+16,305
+22% +$848K 3.75% 9
2021
Q3 		$3.57M Buy
74,788
+4,639
+7% +$233K 3.27% 14
2021
Q2 		$3.49M Buy
70,149
+3,915
+6% +$188K 3.27% 13
2021
Q1 		$2.96M Sell
66,234
-108,020
-62% -$4.9M 3.07% 15
2020
Q4 		$8.02M Buy
174,254
+33,305
+24% +$1.53M 3.14% 16
2020
Q3 		$6.63M Buy
140,949
+38,018
+37% +$1.9M 3.21% 17
2020
Q2 		$5.25M Buy
102,931
+441
+0.4% +$22.6K 2.71% 23
2020
Q1 		$4.85M Sell
102,490
-466
-0.5% -$24.9K 3.13% 17
2019
Q4 		$6.05M Sell
102,956
-526
-0.5% -$29.3K 2.77% 23
2019
Q3 		$5.52M Buy
103,482
+356
+0.3% +$18.3K 2.66% 22
2019
Q2 		$5.16M Buy
+103,126
New +$5.17M 2.49% 26

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clifford Capital Partners's GSK Position: Q4 2024 in Review

Clifford Capital Partners sold out of GSK (GSK) in Q4 2024, closing a stake of 409,669 shares — an estimated $16.7M sold.

Clifford Capital Partners first reported a position in GSK in Q2 2019 and held it in 22 quarters. The position peaked at $16.7M in Q3 2024. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Clifford Capital Partners reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Clifford Capital Partners sold 409,669 GSK shares in Q4 2024, an estimated $16.7M.
  • Clifford Capital Partners first reported a position in GSK in Q2 2019 and held it in 22 quarters.
  • Clifford Capital Partners's GSK position peaked at $16.7M in Q3 2024.
  • 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Clifford Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.